Diffuse large B cell lymphoma (DLBCL), the most common and aggressive form of non-Hodgkin lymphoma, often exhibits multiple genomic aberrations, including mutations in the MYD88 and CD79B genes (6, 7). This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.